Invention Grant
- Patent Title: Thiazole derivatives as kinase inhibitors
- Patent Title (中): 噻唑衍生物作为激酶抑制剂
-
Application No.: US12446140Application Date: 2007-10-16
-
Publication No.: US08168634B2Publication Date: 2012-05-01
- Inventor: Rikki Peter Alexander , Julien Alistair Brown , Karen Viviane Lucile Crépy , Stephen Robert Mack
- Applicant: Rikki Peter Alexander , Julien Alistair Brown , Karen Viviane Lucile Crépy , Stephen Robert Mack
- Applicant Address: BE Brussels
- Assignee: UCB Pharma S.A.
- Current Assignee: UCB Pharma S.A.
- Current Assignee Address: BE Brussels
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- Priority: GB0620818.5 20061019
- International Application: PCT/GB2007/003949 WO 20071016
- International Announcement: WO2008/047109 WO 20080424
- Main IPC: A61K31/535
- IPC: A61K31/535 ; C07D413/04 ; C07D413/14

Abstract:
A series of thiazole derivatives which are substituted in the 2-position by a substituted morpholin-4-yl moiety, being selective inhibitors of P13 kinase enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic conditions.
Public/Granted literature
- US20100298310A1 Thiazole Derivatives as Kinase Inhibitors Public/Granted day:2010-11-25
Information query